IL17A and cancer: We next evaluated the impacts of these IL-17A SNPs on clinicopathological characteristics of LUAD patients, including the cancer stage, primary tumor size, lymph node involvement, distant metastasis, and cell differentiation, and the results are shown in Table 3.